MOG and myeloid sarcoma: Myelin oligodendrocyte glycoprotein antibody (anti-MOG) is the defining biomarker of MOG antibody-associated disease (MOGAD), an inflammatory demyelinating disease that is distinct from multiple sclerosis (MS).